Viatris (VTRS) director settles RSUs into shares and receives 15,890-unit grant

Rhea-AI Filing Summary

Viatris Inc director Vivaldi Coelho Rogerio reported equity compensation activity involving restricted stock units (RSUs) and related common shares. On March 6, 2026, previously granted RSUs representing 23,660 shares of common stock vested in full and were exercised, along with 1,174.4921 dividend equivalent units that had accrued on those RSUs. These derivative securities converted into common stock, leaving no remaining balance from those specific RSUs or dividend units.

On the same date, the director received a new grant of 15,890 RSUs, each representing one share of Viatris common stock, which will vest on March 6, 2027. Following these transactions, the filing shows 46,526 shares of common stock held directly and a separate outstanding RSU award of 15,890 units scheduled to vest in 2027. The activity reflects routine vesting and a new equity award rather than any open-market buying or selling.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vivaldi Coelho Rogerio

(Last) (First) (Middle)

1000 MYLAN BOULEVARD

(Street)

CANONSBURG PA 15317

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Viatris Inc [ VTRS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/06/2026		M		23,660	A	$0	45,351	D
Common Stock	03/06/2026		M		1,175(1)	A	$0	46,526	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	03/06/2026		M			23,660	(2)	(2)	Common Stock	23,660	$0	0	D
Dividend Equivalent Units	$0	03/06/2026		M			1,174.4921	(3)	(3)	Common Stock	1,174.4921	$0	0	D
Restricted Stock Units	$0	03/06/2026		A		15,890		(4)	(4)	Common Stock	15,890	$0	15,890	D

Explanation of Responses:

1. Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.

2. Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026.

3. Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11.

4. Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027.

	/s/ Kevin Macikowski, by power of attorney	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Viatris (VTRS) director Vivaldi Coelho Rogerio report in this Form 4?

The Form 4 shows the director settled vested restricted stock units into common shares and received a new RSU grant. These actions are compensation-related equity movements, not open-market stock purchases or sales, and reflect standard long-term incentive arrangements.

How many Viatris shares did the director acquire through RSU vesting and dividend units?

The director exercised RSUs covering 23,660 shares and 1,174.4921 dividend equivalent units into Viatris common stock. These derivative securities fully converted on March 6, 2026, increasing the director’s directly held common stock position as part of previously awarded equity compensation.

What new restricted stock unit award did the Viatris (VTRS) director receive?

The filing reports a new grant of 15,890 restricted stock units to the director. Each RSU represents one share of Viatris common stock and is scheduled to vest on March 6, 2027, continuing the director’s equity-based incentive alignment with shareholders.

How many Viatris common shares does the director hold after these transactions?

After the RSU and dividend equivalent unit conversions, the Form 4 shows the director holding 46,526 shares of Viatris common stock directly. This figure reflects post-transaction ownership and excludes the separate 15,890 RSUs that will vest in 2027.

Were there any open-market purchases or sales of Viatris (VTRS) stock in this Form 4?

No open-market purchases or sales are reported. All transactions involve RSU and dividend equivalent unit exercises plus a new RSU grant, with zero transaction price per share, indicating compensation-related equity movements rather than discretionary market trading in Viatris stock.

When will the newly granted Viatris restricted stock units vest?

The newly granted 15,890 restricted stock units will vest on March 6, 2027. At vesting, each unit is scheduled to convert into one share of Viatris common stock, subject to the terms of the company’s 2020 Stock Incentive Plan and the award agreement.